HopeStage
Back to all studies
Enrolling By InvitationNCT05659082

Ventral Capsulotomy for Intractable OCD

Device studyAges 18–90United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 90 years.

Listed locations
ProvidenceSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 21, 2022
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
50
Sponsor
Butler Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 90 Years
Official registry ID
NCT05659082
Official title
Show the full official title

Cognition and Magnetic Resonance Imaging After Psychiatric Neurosurgery for Intractable Obsessive-Compulsive Disorder- Phase 2

Recruitment & locations

By invitation

Providence

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Butler Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 90 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies